SLS - Pangali PEG SELLAS Life Sciences Group Inc.
The expected pricing power upon the approval of the Galinpepimut-S vaccine creates powerful growth potential for SELLAS Life Sciences (SLS). The peg_co ratio demonstrates current dynamics, where the 0.00 mark reflects the asset's current state. Diversification through the fight against leukemia minimizes risks, while the status of an innovative yet speculative developer maintains high price volatility amid expectations for clinical trial results.
Rincian analitis perusahaan SELLAS Life Sciences (SLS)
- rega pasar lan target rega analis:
- statistik kapitalisasi pasar:
- data ekuitas miturut neraca:
- indikator beban kredit lan likuiditas emiten:
Koefisien Total Utang marang Modal SELLAS Life Sciences|SLS - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal sellaslifesciences.com|SLS - Utang perusahaan|Rasio utang marang kapitalisasi buku SELLAS Life Sciences Group Inc.|SLS - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan SELLAS Life Sciences|Rasio cepet sellaslifesciences.com
- informasi bathi lan kelipatan valuasi:
SLS - Bathi resik perusahaan|Prakiraan bathi perusahaan SELLAS Life Sciences|SLS - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi sellaslifesciences.com|SLS - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan SELLAS Life Sciences Group Inc.|SLS - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan SELLAS Life Sciences|SLS - Bathi resik saben saham (EPS TTM)|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan sellaslifesciences.com|SLS - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep SELLAS Life Sciences
Analisis fundamental perusahaan:SELLAS Life Sciences Group, Inc. SLS
The SELLAS Life Sciences biotech ecosystem possesses high market potential, yet full product commercialization is constrained by pending FDA approvals. This metric compares market value with profit growth rates, where values below one signal that the asset is undervalued, enabling the identification of promising entry points through an analysis of the PEG ratio.
Pesaing SELLAS Life Sciences
Pangali rega marang bathi tumrap wutah BeiGene Ltd. ONC|Halozyme Inc. - Pangali rega marang bathi tumrap wutah|Pangali PEG Revolution Medicines Corp RVMD|AAPG - Rasio rega marang bathi tumrap wutah|Koefisien bali modal nimbang wutah CGON (cgoncology.com)|URGN: Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Bicara Therapeutics Inc (BCAX)|Rasio rega marang bathi tumrap wutah Personalis Corp|Erasca Oncology (ERAS) - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali PEG DCTH|YMAB - Rega marang bathi kanthi panyesuaian wutah|Rasio rega marang bathi tumrap wutah Aura Biosciences AURA|Candel Therapeutics Inc. - Rasio rega marang bathi tumrap wutah|ARAY - Rasio rega marang bathi tumrap wutah|ACTU: Rasio rega marang bathi tumrap wutah|CTOR: Pangali PEG|TuHURA Biosciences (HURA) - Pangali PEG|Rasio rega marang bathi tumrap wutah Protara Therapeutics, Inc.|Fate Therapeutics Inc (FATE) - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali rega marang bathi tumrap wutah WHWK (Aadi Bioscience Inc)|TCRX (tscan.com) - Koefisien bali modal nimbang wutah|Rasio rega marang bathi tumrap wutah Champions Oncology, Inc. CSBR|XBiotech Inc - Rasio rega marang bathi tumrap wutah|CEL-SCI Corp - Pangali PEG|Kapitalisasi marang bathi resik kanthi nimbang wutah OS Therapies Inc. OSTX|RADX: Pangali PEG|Rasio kapitalisasi marang bathi lan wutah ARTV (Artiva Biotherapeutics)|ANL (Adlai Nortye Ltd) - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah verupharma.com VERU|Pangali rega marang bathi tumrap wutah TPST (Tempest Therapeutics, Inc.)|XLO (xiliotx.com) - Koefisien bali modal nimbang wutah|Rasio rega marang bathi tumrap wutah Renovaro RENB|Kapitalisasi marang bathi resik kanthi nimbang wutah Mural Oncology PLC (MURA)|Kairos Pharma Inc - Pangali PEG|OnKure Therapeutics Inc (OKUR) - Pangali rega marang bathi tumrap wutah|GDTC: Pangali PEG|CRIS - Kapitalisasi marang bathi resik kanthi nimbang wutah|APLM (Apollomics Inc.) - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Tharimmune Corporation THAR|Rasio rega marang bathi tumrap wutah Advanced Biomed Inc (ADVB)|genprex.com - Rasio P/E diaturake wutah|Pangali PEG CLDI (Calidi Biotherapeutics, Inc.)|SBFM - Pangali rega marang bathi tumrap wutah|Xenetic Bio - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Salarius Pharma|Purple Biotech (PPBT) - Rasio rega marang bathi tumrap wutah|AONC - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio rega marang bathi tumrap wutah BeiGene|Checkpoint Therapeutics Inc. (CKPT) - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio rega marang bathi tumrap wutah Elevation Oncology, Inc. (ELEV)|Rasio rega marang bathi tumrap wutah ICAD (icadmed.com)|Rasio rega marang bathi tumrap wutah Ikena Oncology IKNA|Kapitalisasi marang bathi resik kanthi nimbang wutah notablelabs.com (NTBL)|Viracta - Pangali PEG|MorphoSys Inc (MOR) - Pangali rega marang bathi tumrap wutah|NAYA: Pangali PEG|Ascentage (AAPGV) - Pangali PEG
